Clinical Trial Update: Efficacy and Safety of Ginkgo Biloba Extract EGb761® in Patients With Diabetic Retinopathy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating the efficacy and safety of EGb761, a Ginkgo biloba extract, in patients with non-proliferative diabetic retinopathy; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Drugs mentioned

• EGb761 (Ginkgo biloba extract) (Ginkgo biloba extract)

Snippet

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Non-proliferative Diabetic Retinopathy (NPDR) | Phase 2 | Status: NOT_YET_RECRUITING